Managing Unseen Risks: Understanding Recurrence in Early Breast Cancer With No or Limited Nodal Involvement
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Related Articles
Azenosertib Monotherapy Yields Encouraging Responses in Cyclin E1+ PROC
Results from the ZN-c3-001, MAMMOTH, and DENALI trials demonstrated meaningful ORRs with azenosertib in platinum-resistant ovarian cancer.
Quantifying MM disease burden by BCMA?
In this issue of Blood, Ikeda and colleagues successfully demonstrated the utility of soluble B-cell maturation antigen (sBCMA) as a quantitative metric fo
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century – The Cancer Letter
Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to…
Cancer cases on rise in J&K; Over 12,000 cases being registered every year
Cancer cases on rise in J&K; Over 12,000 cases being registered every year
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT
Key PointsRuxolitinib therapy was associated with improvements in lung function for participants with BOS.Clinical responses were more commonly observed in
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
AACR Statement on the New Administration’s Recent Executive Orders and Policy Proposals
The American Association for Cancer Research (AACR) is increasingly concerned about the numerous executive orders and policy proposals that the new administration has issued during…
Recent and Upcoming Advances in Breast Cancer Treatment
Erica S. Doubleday, MS, FNP-C, BSN, RN, outlined upcoming approvals and care options for providers to expect in the breast cancer space.
